| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 7.667 | 35.211 | 24.172 | 27.275 | 32.385 | 4.465 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 7.667 | 35.211 | 24.172 | 27.275 | 32.912 | 4.879 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 3.619 | 23.692 | 12.513 | 17.480 | 19.796 | 1.042 | 0 | 291 | 0 | 0 |
| Gross Profit/Loss - EUR | 4.048 | 11.519 | 11.659 | 9.795 | 13.115 | 3.836 | 0 | -291 | 0 | 0 |
| Net Profit/Loss - EUR | 3.818 | 11.091 | 11.418 | 9.611 | 12.786 | 3.690 | 0 | -291 | 0 | 0 |
| Employees | 0 | 2 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Cadoramed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.688 | 3.678 | 2.425 | 1.809 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 2.535 | 10.107 | 15.507 | 22.226 | 29.513 | 26.425 | 19.764 | 13.643 | 9.557 | 9.182 |
| Inventories | 116 | 0 | 0 | 602 | 151 | 148 | 145 | 0 | 0 | 0 |
| Receivables | 0 | 143 | 36 | 36 | 2.058 | 81 | 92 | 0 | 0 | 0 |
| Cash | 2.419 | 9.964 | 15.471 | 21.589 | 27.305 | 26.196 | 19.528 | 13.643 | 9.557 | 9.182 |
| Shareholders Funds | 4.799 | 12.095 | 16.783 | 21.250 | 28.281 | 25.903 | 19.749 | 13.315 | 9.231 | 9.179 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 424 | 1.690 | 1.150 | 2.785 | 1.233 | 523 | 15 | 329 | 326 | 2 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4618 - 4618" | |||||||||
| CAEN Financial Year |
4618
|
|||||||||
Comments - Cadoramed Srl